Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies

Front Med (Lausanne). 2022 Apr 28:9:892495. doi: 10.3389/fmed.2022.892495. eCollection 2022.

Authors

Ana Sandoval-Rodriguez¹, Aldo Torre², Juan Armendariz-Borunda^{1

3}

Affiliations

¹ Institute of Molecular Biology in Medicine and Gene Therapy, CUCS, University of Guadalajara, Guadalajara, Mexico.
² Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
³ Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexico.

No abstract available

Keywords: MALFD; NAFLD; NASH; liver; steatohepatitis.

Publication types

Editorial